Results 201 to 210 of about 18,376 (235)

Humanization of Drug Metabolism in the <i>Plasmodium berghei</i> Mouse Model for Antimalarial Drug Discovery. [PDF]

ACS Infect Dis
MacLeod AK, Merino C, Viera-Morilla S, Frame L, Tavendale A, Duncan C, Ferguson L, Pinto EG, Simeons FRC, Gomez-Jimenez V, García AB, Riley J, Shishikura Y, Martínez-Martínez MS, Wolf CR, Read KD.   +15 more
europepmc   +1 more source

Prospective observational study to assess the feasibility and safety of appropriate <i>Plasmodium vivax</i> radical cure with tafenoquine or primaquine after quantitative G6PD testing during pilot implementation in Thailand. [PDF]

BMJ Glob Health
Sudathip P, Khantikul N, Saejeng A, Duparc S, Grewal Daumerie P, Lynch C, Jambert E, Viboonsanti S, Areechokchai D, Kanjanasuwan J, Thong-Ard T, Kowsurat P, Borghini-Fuhrer I, Padungtod C.   +13 more
europepmc   +1 more source

Anti-Relapse Efficacy of Transdermal Primaquine Against Plasmodium Cynomolgi B in Rhesus Monkeys

, 1993
S. K. Puri, G. K. Jain, Satyawan Singh, J Ps Sarin, G. P. Dutta   +4 more
openalex   +1 more source

Strengthening country ownership of national antimalarial policymaking: insights from Laos, Pakistan and the Solomon Islands. [PDF]

Malar J
Ruwanpura VSH, Phongchantha V, Price RN, Grietens KP, Thriemer K, Lynch CA.   +5 more
europepmc   +1 more source

Abstracts of the 9th International Conference on Plasmodium vivax Research (ICPvR) 2025. [PDF]

Malar J
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Primaquine and methemoglobin

Clinical Pharmacology & Therapeutics, 1964
Methemoglobin formation occurring as a toxic manifestation of primaquine was studied in volunteers to determine whether or not it is an example of genetic polymorphism. No evidence of polymorphism was found.
W K, COWAN, D A, EVANS
openaire   +2 more sources